Validation of Serum Biomarkers Derived from Proteomic Analysis for the Early Screening of Preeclampsia

Treatment of Preeclampsia: Current Approach and Future Perspectives

(2014) Ecaterina Berzan et al.   CURRENT HYPERTENSION REPORTS

Clinical proteomics in obstetrics and neonatology

(2014) Julie Klein et al.   Expert Review of Proteomics

Impact of pre-gravid body mass index and body mass index change on preeclampsia and gestational diabetes in singleton and twin pregnancies

(2014) Miha Lucovnik et al.   Journal of Maternal-Fetal & Neonatal Medicine

Excessive weight gain and hypertensive disorders of pregnancy in the obese patient

(2014) Suchitra Chandrasekaran et al.   Journal of Maternal-Fetal & Neonatal Medicine

Risk Factors of Pre-Eclampsia/Eclampsia and Its Adverse Outcomes in Low- and Middle-Income Countries: A WHO Secondary Analysis

(2014) Ver Luanni Bilano et al.   PLoS One

RASSF1Ain maternal plasma as a molecular marker of preeclampsia

(2013) Nikolas Papantoniou et al.   PRENATAL DIAGNOSIS

Quantitative Proteomic (iTRAQ) Analysis of 1st Trimester Maternal Plasma Samples in Pregnancies at Risk for Preeclampsia

(2012) Varaprasad Kolla et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Proteomics in hypertension

(2012) D M Carty et al.   JOURNAL OF HUMAN HYPERTENSION

Efficiency of first-trimester growth restriction and low pregnancy-associated plasma protein-A in predicting small for gestational age at delivery

(2012) Jeanine F. Carbone et al.   PRENATAL DIAGNOSIS

Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption

(2011) Jenni K. Ranta et al.   European Journal of Obstetrics & Gynecology and Reproductive Biology

Maternal serum insulin-like growth factor-binding protein-3 (IGFBP-3) at 11–13 weeks in preeclampsia

(2011) S Sifakis et al.   JOURNAL OF HUMAN HYPERTENSION

Maternal Serum Human Placental Growth Hormone (hPGH) at 11 to 13 Weeks of Gestation in Preeclampsia

(2010) Stavros Sifakis et al.   HYPERTENSION IN PREGNANCY

Association between pregnancy complications and small-for–gestational-age birth weight defined by customized fetal growth standard versus a population-based standard

(2010) Anthony O. Odibo et al.   Journal of Maternal-Fetal & Neonatal Medicine

Comprehensive Maternal Serum Proteomic Profiles of Preclinical and Clinical Preeclampsia

(2010) Juha Rasanen et al.   JOURNAL OF PROTEOME RESEARCH

Early-Pregnancy Multiple Serum Markers and Second-Trimester Uterine Artery Doppler in Predicting Preeclampsia

(2010) Basky Thilaganathan et al.   OBSTETRICS AND GYNECOLOGY

First-Trimester Prediction of Hypertensive Disorders in Pregnancy

(2009) Leona C.Y. Poon et al.   HYPERTENSION

Early-Onset Preeclampsia and the Prevalence of Postpartum Metabolic Syndrome

(2009) Eva Stekkinger et al.   OBSTETRICS AND GYNECOLOGY

A proteomic approach identifies early pregnancy biomarkers for preeclampsia: Novel linkages between a predisposition to preeclampsia and cardiovascular disease

(2009) Marion Blumenstein et al.   PROTEOMICS

Mass spectrometry-based proteomics in reproductive medicine

(2008) Aggeliki Kolialexi et al.   MASS SPECTROMETRY REVIEWS

ADAM12s in maternal serum as a potential marker of pre-eclampsia

(2008) Kevin Spencer et al.   PRENATAL DIAGNOSIS

Cystatin C and Preeclampsia: A Case Control Study

(2008) Nora Franceschini et al.   RENAL FAILURE

Low levels of maternal serum PAPP-A in the first trimester and the risk of pre-eclampsia

(2007) Kevin Spencer et al.   PRENATAL DIAGNOSIS